Programmed cell death-ligand 2: A neglected but important target in the immune response to cancer?
Programmed cell death-ligand 2 (PD-L2) is one of the two ligands of the programmed cell death-1 (PD-1) receptor, an inhibitory protein mainly expressed on activated immune cells that is targeted in the clinic, with successful and remarkable results. The PD-1/PD-Ls axis was shown to be one of the mos...
Main Authors: | Cinzia Solinas, Marco Aiello, Esdy Rozali, Matteo Lambertini, Karen Willard-Gallo, Edoardo Migliori |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-10-01
|
Series: | Translational Oncology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S193652332030303X |
Similar Items
-
Programmed Death Ligand 2 in Cancer-Induced Immune Suppression
by: Esdy N. Rozali, et al.
Published: (2012-01-01) -
Chikungunya-attributable deaths: A neglected outcome of a neglected disease.
by: Antonio S Lima Neto, et al.
Published: (2019-09-01) -
Programmed death ligand-1/programmed death-1 inhibition therapy and programmed death ligand-1 expression in urothelial bladder carcinoma
by: Wei-Bo Yu, et al.
Published: (2019-09-01) -
Elevated Expression of Programmed Death-1 and Programmed Death Ligand-1 Negatively Regulates Immune Response against Cervical Cancer Cells
by: Zhifang Chen, et al.
Published: (2016-01-01) -
Comprehensive insights into the effects and regulatory mechanisms of immune cells expressing programmed death-1/programmed death ligand 1 in solid tumors
by: Min Liu, et al.
Published: (2020-08-01)